The Aches and Pains of an Isotretinoin Course

Why does an isotretinoin course cause joint and muscle aches?

Isotretinoin's most talked-about side effects are dryness — skin, lips, eyes — but aching joints and sore muscles are close behind, showing up most often in the low back, knees, hips, and sometimes the hands. The systematic evidence review of isotretinoin trials catalogs joint and muscle symptoms among the drug's recognized adverse effects, alongside its well-established dryness profile 1Ref 1Costa CS, Bagatin E, Martimbianco ALC, et al. (2018).Oral isotretinoin for acne.Joint and muscle symptoms are among the recognized adverse effects catalogued in the systematic evidence review of oral isotretinoin trials, alongside the drug's mucocutaneous effects.. Isotretinoin is a retinoid that acts on tissue throughout the body, not only the skin, which is part of why its side-effect list reaches well beyond the obvious.

The aches tend to feel like an overuse injury or a mild flu-like soreness rather than true joint swelling or structural damage. Exercise, especially high-impact activity like running or weightlifting, tends to make the aching more noticeable, since the affected tissue is already under some added strain from the medication itself.

How common is this, and how bad does it usually get?

Most people taking isotretinoin notice at least some musculoskeletal discomfort, and for most of them it stays mild — a stiff lower back after sitting too long, achy knees on stairs, sore shoulders after a workout that wouldn't normally leave a mark. For the large majority, this is uncomfortable rather than damaging, and it resolves once the course ends.

A smaller share of people find the aching genuinely limits activity — skipping a usual run, avoiding stairs, or scaling back a workout routine for weeks at a stretch. That pattern is worth mentioning at a monthly visit rather than quietly tolerating, since dose is one of the levers a prescriber can adjust if the aching feels disproportionate to what someone expected when starting treatment.

The location of the ache can shift over the course of treatment, too — someone might notice low-back stiffness in the first month and knee soreness by the third, rather than the same joint aching the whole time. That kind of migration is typical and doesn't usually signal anything beyond the same underlying, reversible effect showing up in a different place.

When during the course the aches tend to show up

Joint and muscle aches most often start in the first four to eight weeks of a course, often while the dose is still being increased toward its target, and they can persist at a lower level for the rest of treatment. Charting an isotretinoin timeline helps explain the pattern: side effects tend to cluster early, then plateau or ease even as treatment continues at a steady dose.

For most people, the aching fades within days to a couple of weeks after the last dose, following the same general recovery arc as the dryness and other reversible effects isotretinoin is known for. Aching that starts later in a course rather than at the outset, or that keeps intensifying rather than plateauing, is less typical of the usual pattern and worth mentioning at a visit.

What helps day to day

Scaling back the intensity of exercise — lighter weights, shorter runs, more rest days between sessions — is the most commonly suggested adjustment, since high-impact activity is what most reliably triggers or worsens the aching. Gentle stretching, a warm compress or bath, and simply allowing more recovery time between workouts are the practical tools most people reach for first.

None of this requires giving up activity entirely for most people; it's more a temporary dial-down than a full stop. Some people find switching from running or heavy lifting to walking, swimming, or yoga for the duration of the course keeps them active without aggravating the joints as much. What works varies enough from person to person that it's worth experimenting with rather than assuming one approach fits everyone, and easing back in gradually after the course ends tends to go better than resuming full intensity immediately.

Hydration and the dryness side of isotretinoin can compound how achy someone feels day to day, if only because general discomfort tends to feel more noticeable on top of chapped lips, dry eyes, and flaky skin. Addressing the dryness with the usual measures — heavier moisturizer, lip balm kept within reach, artificial tears — doesn't treat the joint aches directly, but it does remove one layer of overall discomfort stacking on top of another.

When to loop in the prescriber

Aching that stays generalized — both knees, the low back, several joints at once — and eases somewhat with rest is the expected pattern and rarely needs a dose change on its own. What's different is pain, swelling, warmth, or redness confined to a single joint, or aching severe enough to significantly limit walking or basic daily movement; those patterns are less typical of isotretinoin-related aches and deserve a direct conversation rather than waiting for the next scheduled visit.

The same monthly visits that check isotretinoin blood tests double as a built-in checkpoint for this, and prescribers generally expect to hear about side effects that go beyond minor nuisance. Isotretinoin doses can be adjusted mid-course specifically because of side-effect burden, so aching that's genuinely disruptive to daily life is worth raising rather than pushing through it silently until the next appointment happens to come around.

How aches fit with the rest of an isotretinoin course

Joint and muscle aches are one entry on a longer list of body-wide effects people track during isotretinoin — alongside questions like does isotretinoin thin your hair? and concerns about isotretinoin and mood. All three are real, reported effects, but they differ in how reversible and how urgent they are: the musculoskeletal aches and hair changes are typically temporary and resolve after the course ends, while mood changes are the one category where guidance calls for closer, ongoing attention rather than a wait-and-see approach.

Other feared risks have been studied specifically and turned out smaller than expected — a large study looking at inflammatory bowel disease, for instance, found no clinically meaningful increase in risk among people taking isotretinoin 2Ref 2Tan NKW, Tang A, Lim RK, et al. (2023).Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study.A large-scale study found no clinically meaningful increased risk of inflammatory bowel disease among people taking isotretinoin, illustrating that a separate, commonly feared systemic risk has not held up under scrutiny., a useful reminder that not every rumored side effect holds up under scrutiny. Isotretinoin is generally reserved for acne that's severe, scarring, or has resisted other treatment 3Ref 3Reynolds RV, Yeung H, Cheng CE, et al. (2024).Guidelines of care for the management of acne vulgaris.Oral isotretinoin is strongly recommended for acne that is severe, scarring, psychosocially burdensome, or refractory, providing context for why someone would be undergoing a course., and for most people who reach that point in their acne, temporary aches are a trade-off they're willing to make rather than a reason to stop partway through.